X @Bloomberg
Bloomberg·2026-02-13 23:13
The rejection of Disc Medicines experimental compound for a rare and devastating disorder by the FDA is the latest example of the growing uncertainty at the nation’s top drug regulator https://t.co/6vR7cyr3WO ...